Oral Minoxidil for Chemotherapy-Induced Alopecia.
Study Design
- Studientyp
- Case Reports
- Stichprobengröße
- 1
- Population
- 64-year-old patient with chemotherapy-induced alopecia
- Intervention
- Oral Minoxidil for Chemotherapy-Induced Alopecia. None
- Vergleichsgruppe
- None
- Primärer Endpunkt
- Hair regrowth in chemotherapy-induced alopecia
- Wirkungsrichtung
- Positive
- Verzerrungsrisiko
- High
Abstract
INTRODUCTION: Chemotherapy-induced alopecia (CIA), one of the most dramatic side effects of chemotherapy, occurs in approximately 65% of patients receiving cytotoxic drugs. CASE PRESENTATION: We report the case of a patient, 64 years old, affected by chemotherapy-induced alopecia treated with oral minoxidil with good results. DISCUSSION/CONCLUSION: Our case may be useful in the literature to propose a new therapy for this pathology that is fundamentally very difficult to treat.
Zusammenfassung
The case of a patient affected by chemotherapy-induced alopecia treated with oral minoxidil with good results may be useful in the literature to propose a new therapy for this pathology that is fundamentally very difficult to treat.
Used In Evidence Reviews
Similar Papers
Annual review of nutrition · 2004
Secular trends in dietary intake in the United States.
Journal of the American Academy of Dermatology · 2002
A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
Journal of the American Academy of Dermatology · 2017
The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.
Current problems in dermatology · 2015
Alopecia areata.
Drug design, development and therapy · 2019
Minoxidil and its use in hair disorders: a review.
Journal of cosmetic dermatology · 2021